ArticleJournal of neuroendovascular therapy2026
Clinical Utility and Limitations of Photon-Counting Detector CTA in the Follow-Up of Flow Diverter Stent.
Article in Journal of neuroendovascular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Flow diverters (FDs) are widely used to treat intracranial aneurysms, with DSA serving as the gold standard for follow-up evaluation. Although a few studies have reported the use of photon-counting detector CTA (PCD-CTA) for minimally invasive follow-up after standalone FD treatment, PCD-CTA after coil-assisted FD placement has never been documented. Methods: We retrospectively analyzed 11 patients who underwent FD placement between May 2023 and December 2024, all of whom underwent post-procedural evaluation with PCD-CTA. Patients were categorized into 2 groups: standalone FD (n = 6) and coil-assisted FD (n = 5). PCD-CTA was performed on postoperative day 1, at 6 months, and at 12 months. Metal artifact reduction was applied in the coil-assisted group. Results: In the standalone FD group, PCD-CTA enabled reliable assessment of the in-stent lumen, FD apposition to the parent artery, and aneurysm occlusion, with findings consistent with those of DSA. In the coil-assisted FD group, when coils extended near the FD, evaluation of the in-stent lumen, FD-to-parent artery apposition, and aneurysm occlusion was hindered by metal artifacts in slices containing coils. Conversely, when coils were absent near the FD, partial visualization of intra-aneurysmal contrast was possible, although residual aneurysms tended to be underestimated. Conclusion: PCD-CTA demonstrated diagnostic performance comparable to that of DSA for postoperative evaluation following standalone FD placement. However, in coil-assisted FD cases, postoperative assessment remained limited by coil-related metal artifacts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.